For research use only. Not for therapeutic Use.
Procainamide（Cat No.:I035029）is a Class Ia antiarrhythmic agent used to treat various cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, and premature ventricular contractions. It works by blocking sodium channels, slowing conduction velocity, and prolonging the action potential and refractory period in myocardial tissue. Administered orally or intravenously, procainamide is metabolized to N-acetylprocainamide (NAPA), which also has antiarrhythmic properties. Monitoring is essential due to potential side effects like QT prolongation, lupus-like syndrome, and blood dyscrasias. It remains important in electrophysiological studies and emergency arrhythmia management in clinical and research settings.
| CAS Number | 51-06-9 |
| Synonyms | 4-amino-N-[2-(diethylamino)ethyl]benzamide |
| Molecular Formula | C13H21N3O |
| Purity | ≥95% |
| IUPAC Name | 4-amino-N-[2-(diethylamino)ethyl]benzamide |
| InChI | InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17) |
| InChIKey | REQCZEXYDRLIBE-UHFFFAOYSA-N |
| SMILES | CCN(CC)CCNC(=O)C1=CC=C(C=C1)N |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
